These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 15223247)

  • 1. MMP-9 microsatellite polymorphism and multiple sclerosis.
    Fiotti N; Zivadinov R; Altamura N; Nasuelli D; Bratina A; Tommasi MA; Bosco A; Locatelli L; Grop A; Cazzato G; Guarnieri G; Giansante C; Zorzon M
    J Neuroimmunol; 2004 Jul; 152(1-2):147-53. PubMed ID: 15223247
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MMP-9 microsatellite polymorphism and susceptibility to exudative form of age-related macular degeneration.
    Fiotti N; Pedio M; Battaglia Parodi M; Altamura N; Uxa L; Guarnieri G; Giansante C; Ravalico G
    Genet Med; 2005 Apr; 7(4):272-7. PubMed ID: 15834245
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Matrix metalloproteinase-9 and matrix metalloproteinase-2 gene polymorphisms in multiple sclerosis.
    Benesová Y; Vasků A; Stourac P; Hladíková M; Beránek M; Kadanka Z; Novotná H; Bednarík J
    J Neuroimmunol; 2008 Dec; 205(1-2):105-9. PubMed ID: 18835646
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Polymorphism analysis suggests that the gelatinase B gene is not a susceptibility factor for multiple sclerosis.
    Nelissen I; Vandenbroeck K; Fiten P; Hillert J; Olsson T; Marrosu MG; Opdenakker G
    J Neuroimmunol; 2000 Jun; 105(1):58-63. PubMed ID: 10713364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CCR5-Delta32 genetic polymorphism associated with benign clinical course and magnetic resonance imaging findings in Brazilian patients with multiple sclerosis.
    Kaimen-Maciel DR; Reiche EM; Brum Souza DG; Frota Comini ER; Bobroff F; Morimoto HK; Ehara Watanabe MA; Carvalho De Oliveira J; Matsuo T; Lopes J; Donadi EA
    Int J Mol Med; 2007 Sep; 20(3):337-44. PubMed ID: 17671738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MMP-9 microsatellite polymorphism and susceptibility to carotid arteries atherosclerosis.
    Fiotti N; Altamura N; Fisicaro M; Carraro N; Uxa L; Grassi G; Torelli L; Gobbato R; Guarnieri G; Baxter BT; Giansante C
    Arterioscler Thromb Vasc Biol; 2006 Jun; 26(6):1330-6. PubMed ID: 16574900
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single nucleotide polymorphism in the MMP-9 gene is associated with susceptibility to develop multiple sclerosis in an Italian case-control study.
    La Russa A; Cittadella R; De Marco EV; Valentino P; Andreoli V; Trecroci F; Latorre V; Gambardella A; Quattrone A
    J Neuroimmunol; 2010 Aug; 225(1-2):175-9. PubMed ID: 20471697
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dinucleotide repeat polymorphism of matrix metalloproteinase-9 gene is associated with diabetic nephropathy.
    Maeda S; Haneda M; Guo B; Koya D; Hayashi K; Sugimoto T; Isshiki K; Yasuda H; Kashiwagi A; Kikkawa R
    Kidney Int; 2001 Oct; 60(4):1428-34. PubMed ID: 11576356
    [TBL] [Abstract][Full Text] [Related]  

  • 9. MMP-9 microsatellite polymorphism: association with the progression of intima-media thickening and constrictive remodeling of carotid atherosclerotic plaques.
    Fiotti N; Altamura N; Fisicaro M; Carraro N; Adovasio R; Sarra VM; Uxa L; Guarnieri G; Baxter BT; Giansante C
    Atherosclerosis; 2005 Oct; 182(2):287-92. PubMed ID: 16159601
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association of the MMP-3 5A/6A gene polymorphism with multiple sclerosis in patients from Serbia.
    Djurić T; Zivković M; Stanković A; Dincić E; Raicević R; Alavantić D
    J Neurol Sci; 2008 Apr; 267(1-2):62-5. PubMed ID: 17942123
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MMP-2 -1575G/A polymorphism modifies the onset of optic neuritis as a first presenting symptom in MS?
    Gašparović I; Čizmarević NS; Lovrečić L; Perković O; Lavtar P; Sepčić J; Jazbec SŠ; Kapović M; Peterlin B; Ristić S
    J Neuroimmunol; 2015 Sep; 286():13-5. PubMed ID: 26298319
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Matrix metalloproteinase-9 -1562 C/T gene polymorphism in Serbian patients with multiple sclerosis.
    Zivković M; Djurić T; Dincić E; Raicević R; Alavantić D; Stanković A
    J Neuroimmunol; 2007 Sep; 189(1-2):147-50. PubMed ID: 17655938
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Functional MMP-9 polymorphisms modulate plasma MMP-9 levels in multiple sclerosis patients.
    Fernandes KS; Brum DG; Palei AC; Sandrim VC; Guerreiro CT; Tanus-Santos JE; Barreira AA
    J Neuroimmunol; 2012 Aug; 249(1-2):56-9. PubMed ID: 22608171
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase-9 genotypes and haplotypes are associated with multiple sclerosis and with the degree of disability of the disease.
    Fernandes KS; Brum DG; Sandrim VC; Guerreiro CT; Barreira AA; Tanus-Santos JE
    J Neuroimmunol; 2009 Sep; 214(1-2):128-31. PubMed ID: 19631393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. P-selectin glycoprotein ligand-1 variable number of tandem repeats (VNTR) polymorphism in patients with multiple sclerosis.
    Scalabrini D; Galimberti D; Fenoglio C; Comi C; De Riz M; Venturelli E; Castelli L; Piccio L; Ronzoni M; Lovati C; Mariani C; Monaco F; Bresolin N; Scarpini E
    Neurosci Lett; 2005 Nov; 388(3):149-52. PubMed ID: 16039046
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gelatinase B, PECAM-1 and MCP-3 gene polymorphisms in Belgian multiple sclerosis.
    Nelissen I; Dubois B; Goris A; Ronsse I; Carton H; Opdenakker G
    J Neurol Sci; 2002 Aug; 200(1-2):43-8. PubMed ID: 12127674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association of a decreased number of d(CA) repeats in the matrix metalloproteinase-9 promoter with glomerulosclerosis susceptibility in mice.
    Fornoni A; Wang Y; Lenz O; Striker LJ; Striker GE
    J Am Soc Nephrol; 2002 Aug; 13(8):2068-76. PubMed ID: 12138138
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Difference in disease burden and activity in pediatric patients on brain magnetic resonance imaging at time of multiple sclerosis onset vs adults.
    Waubant E; Chabas D; Okuda DT; Glenn O; Mowry E; Henry RG; Strober JB; Soares B; Wintermark M; Pelletier D
    Arch Neurol; 2009 Aug; 66(8):967-71. PubMed ID: 19667217
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Polymorphisms of the promoter regions of matrix metalloproteinases genes MMP-1 and MMP-9 in breast cancer.
    Przybylowska K; Kluczna A; Zadrozny M; Krawczyk T; Kulig A; Rykala J; Kolacinska A; Morawiec Z; Drzewoski J; Blasiak J
    Breast Cancer Res Treat; 2006 Jan; 95(1):65-72. PubMed ID: 16267613
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Safety profile of tissue plasminogen activator treatment among stroke patients carrying a common polymorphism (C-1562T) in the promoter region of the matrix metalloproteinase-9 gene.
    Montaner J; Fernández-Cadenas I; Molina CA; Monasterio J; Arenillas JF; Ribó M; Quintana M; Chacón P; Andreu AL; Alvarez-Sabín J
    Stroke; 2003 Dec; 34(12):2851-5. PubMed ID: 14605329
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.